Proof of region-specific multipotent progenitors in human breast epithelia

Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10102-E10111. doi: 10.1073/pnas.1714063114. Epub 2017 Nov 6.

Abstract

The human breast parenchyma consists of collecting ducts and terminal duct lobular units (TDLUs). The TDLU is the site of origin of most breast cancers. The reason for such focal susceptibility to cancer remains poorly understood. Here, we take advantage of a region-specific heterogeneity in luminal progenitors to interrogate the differentiation repertoire of candidate stem cells in TDLUs. We show that stem-like activity in serial passage culture and in vivo breast morphogenesis relies on the preservation of a myoepithelial phenotype. By enrichment for region-specific progenitors, we identify bipotent and multipotent progenitors in ducts and TDLUs, respectively. We propose that focal breast cancer susceptibility, at least in part, originates from region-specific myoepithelial progenitors.

Keywords: breast; myoepithelial cell; progenitors; stem cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antigens, CD / genetics
  • Antigens, CD / metabolism
  • Biomarkers / metabolism
  • Cell Culture Techniques
  • Cell Differentiation
  • Cell Transformation, Neoplastic / genetics*
  • Cell Transformation, Neoplastic / metabolism
  • Cell Transformation, Neoplastic / pathology
  • Epithelial Cells / cytology*
  • Epithelial Cells / metabolism
  • Female
  • Gene Expression
  • Humans
  • Keratin-19 / genetics
  • Keratin-19 / metabolism
  • Mammary Glands, Human / cytology*
  • Mammary Glands, Human / metabolism
  • Middle Aged
  • Multipotent Stem Cells / cytology*
  • Multipotent Stem Cells / metabolism
  • Muscle Cells / cytology*
  • Muscle Cells / metabolism
  • Myoepithelioma / diagnosis
  • Myoepithelioma / genetics
  • Myoepithelioma / metabolism
  • Myoepithelioma / pathology
  • Organ Specificity
  • Primary Cell Culture
  • Prognosis

Substances

  • Antigens, CD
  • Biomarkers
  • Keratin-19